The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of ipilimumab in patients with advanced melanoma and spontaneous preexisting immune response to NY-ESO-1 (CTLA-4 NY-ESO-1).
 
Georg Martin Haag
Consulting or Advisory Role - Lilly; Sanofi
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Celgene
 
Jessica Cecile Hassel
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Consulting or Advisory Role - Amgen; GlaxoSmithKline
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Inka Zoernig
No Relationships to Disclose
 
Niels Halama
Honoraria - Baxter; Bristol-Myers Squibb; Menarini; Roche Pharma AG
Speakers' Bureau - Roche Pharma AG
Research Funding - Baxter
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Philipp Beckhove
No Relationships to Disclose
 
Irini Karapanagiotou-Schenkel
No Relationships to Disclose
 
Alexander Enk
Honoraria - Allergika; Bristol-Myers Squibb; Galderma; MSD; Roche Pharma AG
Consulting or Advisory Role - Allergika; Biotest; Bristol-Myers Squibb; Galderma; MSD; Roche Pharma AG
 
Dirk Jaeger
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche Pharma AG